欢迎访问《中国临床药理学与治疗学》杂志官方网站,今天是

中国临床药理学与治疗学 ›› 2019, Vol. 24 ›› Issue (8): 866-871.doi: 10.12092/j.issn.1009-2501.2019.08.004

• 基础研究 • 上一篇    下一篇

PHA-767491抑制CDC-7的表达在子宫内膜癌ishikawa细胞系中的作用研究

王庆玮,丁 锦,吕爰爰,罗贤臣,倪观太   

  1. 皖南医学院第一附属医院妇产科,芜湖 241000,安徽
  • 收稿日期:2019-01-14 修回日期:2019-02-27 出版日期:2019-08-26 发布日期:2019-08-30
  • 通讯作者: 倪观太,男,副教授,硕士生导师,研究方向:妇科肿瘤及盆底疾病。 E-mail:ngtiger@aliyun.com
  • 作者简介:王庆玮,女,硕士研究生,研究方向:妇科肿瘤及盆底疾病。 Tel:13505595719 E-mail:wqw0116@126.com
  • 基金资助:

    安徽省高校自然科学类重点科研项目(KJ2018A0267)

Effects of PHA-767491 on the inhibition of CDC-7 expression in endometrial cancer ishikawa cell line

WANG Qingwei, DING Jin, LV Yuanyuan, LUO Xianchen, NI Guantai   

  1. Department of Obstetrics and Gynecology, the First Affiliated Hospital of Wannan Medical College, Wuhu 241000, Anhui, China
  • Received:2019-01-14 Revised:2019-02-27 Online:2019-08-26 Published:2019-08-30

摘要:

目的:PHA-767491抑制CDC-7的表达对子宫内膜癌ishikawa细胞系的增殖、侵袭、迁移以及凋亡产生的作用。方法:配置PHA-767491至各实验所需浓度,使其作用于子宫内膜癌ishikawa细胞系。CCK-8法用于检测ishikawa细胞系的增殖能力及明确IC50。运用qRT-PCR法,检测药物PHA-767491对ishikawa细胞中的CDC-7 mRNA的表达的影响。利用划痕实验,检测PHA-767491对于ishikawa细胞迁移能力的影响。用Transwell法检测药物影响ishikawa细胞的侵袭能力。流式细胞术Annexin V/PI双染色法检测药物PHA-767491影响ishikawa细胞的凋亡能力。结果:CCK-8的结果得出,药物PHA-767491能够有效地抑制ishikawa细胞系增殖的能力,得出24 h药物IC50等于9.51 μmol/L。qRT-PCR的结果证明:PHA-767491抑制ishikawa细胞中CDC-7 mRNA的显著表达。划痕实验的结果表明:PHA-767491可抑制ishikawa细胞的迁移能力。Transwell结果表明:药物PHA-767491有效地抑制ishikawa细胞的侵袭能力。流式细胞术结果证明:PHA-767491可以促进ishikawa细胞的凋亡。结论:PHA-767491能够显著抑制子宫内膜癌细胞ishikawa中CDC-7的表达,降低了ishikawa细胞增殖和迁移、侵袭能力,并且可明确诱导ishikawa细胞的凋亡。

关键词: PHA-767491, CDC-7, 子宫内膜癌, 增殖, 迁移, 侵袭, 凋亡

Abstract:

AIM: To investigate the effects of PHA-767491 on the inhibition of CDC7 expression on proliferation, invasion, migration and apoptosis of endometrial cancer ishikawa cell line. METHODS: Different concentrations of PHA-767491 were used to treat the endometrial cancer ishikawa cell line. The proliferation ability of ishikawa cells and the IC50 were determined by CCK-8 method. RT-PCR was used to detect the effect of PHA-767491 on the expression of CDC-7 mRNA in ishikawa cells. The migration ability of the cells was then examined using a scratch test. The transwell chamber method was applied to detect the invasive ability of ishikawa cells.Flow cytometry Annexin V/PI double staining was used to detect cell apoptosis. RESULTS:The results of CCK-8 assay showed that PHA-767491 significantly inhibited the proliferation of endometrial cancer ishikwa cells with an IC50 of 9.51 μmol/L at 24 hours. RT-PCR showed that PHA-767491 significantly inhibited the expression of Cdc-7 mRNA in ishikawa cells. Scratch test showed that PHA-767491 effectively inhibited the migration ability of ishikawa cells. Transwell chamber results showed that PHA-767491 inhibited the invasion of ishikawa cells.PHA-767491 significantly induced ishikawa cells apoptosis.CONCLUSION: PHA-767491 can significantly inhibit the expression of CDC-7 in ishikawa of endometrial cancer cells, which can significantly reduce the proliferation, migration and invasion and induce apoptosis of ishikawa cells.

Key words: PHA-767491, CDC-7, endometrial cancer, proliferation, migration, invasion, apoptosis

中图分类号: